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PROSTAGLANDIN E2 plays a role in cytokine produc-
tion presumably by altering intracellular levels of
cAMP. In this paper, we report on the differential
expression of cytokine genes in murine macro-
phages in response to stimulation with activators
of cAMP. Macrophages were cultured with or
without cAMP activators in the presence or
absence of LPS. Prior to treatment, macrophages
do not express interleukin-l, but do express low
levels of turnout necrosis factor and platelet-
derived growth factor B chain mRNAs. After
culture with cAMP-inducers, including PGE2, dibu-
tyryl cAMP and forskolin, PDGF B chain mRNA is
induced. Forskolin, for example, induced expres-
sion PDGF B chain mRNA to a level ranging from
25% to 200% of the level induced by LPS in 6 h. In
contrast, cAMP-inducers enhance the expression
of IL-I and TNF- mRNAs, but only in the
presence of LPS. The combination of forskolin
and LPS does not appear to act synergistically on
PDGF B chain mRNA levels, suggesting that LPS-
stimulated effects are not mediated through a
cAMP-dependent pathway. Furthermore, macro-
phages differentially express cytokine genes in
response to treatment with inducers of intracel-
lular c_AMP.
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Introduction
A variety of diseases characterized by fibrosis
share common elements. The pathogenesis of
these disorders includes the proliferation of
fibroblasts and the deposition of extracellular
matrix (for a review see Reference 1). This often
begins as an inflammatory reaction with leuko-
cyte infiltration followed by the elaboration of
cytokines. In the absence of inhibitory signals,
the aberrant production of these mediators sus-
tains the connective tissue accumulation which
results in permanent alteration in tissue structure
and function.
Macrophages play a central role in the tissue
response to injury by releasing cytokines and
mediate immune-mesenchymal cell interactions
and trigger the proliferation fibroblasts and the
deposition of connective tissue.
2 Although the
mechanisms responsible for the activation of
macrophages are not fully understood, evidence
suggests that soluble factors including cytokines
and arachidonic acid metabolites, including pros-
taglandin .E2 (PGE2), play a critical role in the
process.3’4 We have previously reported on the
induction of expression of PDGF genes in rat
peritoneal macrophage in response to treatment
with cytokines, including interleukin-2,
5 and
herein examine the role of PGE2 and agents
which stimulate the accumulation of intracellular
cJkMP on the expression of the PDGF B chain
gene in the murine macrophage cell line ANA-1.
Materials and Methods
Reagents: Forskolin, dibutyryl-cAMP (dBcAMP),
8-bromo-cAMP, isomethyl-3-isobutylxanthine
(IBMX), cholera toxin, prostaglandin E2 (POE2)
and dibutyryl-cGMP (dBcGMP) were obtained
from Sigma Chemicals (St. Louis, MO, USA).
Lipopolysaccharide (LPS)was purchased from
Difco (Detroit, MI, USA).
Culture of cells: The ANA-1 murine macrophage
cell line was obtained from Dr Luigi Varesio
(NCI-FCRDC, Frederick, MD, USA).6 Prior to sti-
mulation, cells were washed and incubated at
1 x 106 cells/ml in RPMI 1640 containing 1% FBS
(with penicillin sulfate, streptomycin and gluta-
mine) with or without agents which alter intra-
cellular cAMP in the presence or absence of LPS
for various periods of time.
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RNA isolation and hybridization: Total cellular
RNA was isolated using the RNAzol Method
(Biotecx, Houston, TX, USA) according to the
manufacturer’s specifications. Northern blot
analysis was performed with 10 tg of RNA and
probed with cDNA probes labelled by random
priming with 32p -dCTP as described previously.
Cells were maintained as a semi-adherent culture
in RPMI 1640 medium supplemented with 10%
fetal bovine serum (FBS), 100bt/ml penicillin
sulfate, 100 l.tg/ml streptomycin, and 2mM gluta-
mine (GIBCO, Grand Island, NY, USA) and pas-
sages, cDNA probes used in these studies were
obtained from the following sources: PDGF B
chain (c-sis) from ATCC (Rockville, MD, USA);
human TNF<z from Dr S. Socher (Merck, Sharp &
Dohme Res. Labs., West Point, PA, USA); human
IL-I[ from Dr D. Carter (The Upjohn Co, Kalama-
zoo, MI, USA); and chicken [-actin cDNA from Dr
D.W. Cleveland (Johns Hopkins Univ., Baltimore,
MD, USA). Equivalent amounts of total RNA/lane
were assessed by monitoring 28S and 18S riboso-
mal RNA.
Immunoblot analysis of cytokine protein levels:
To determine cytokine protein levels, immuno-
blot analysis was performed as previously descri-
beds with the following minor modifications.
Supernatants (10011) from cultured cells were
blotted on nitrocellulose filters. The filters were
blocked with gelatin and sequentially incubated
with anti-human PDGF BB antibody (Genzyme,
Cambridge, MA) followed by biotin-conjugated
anti-rabbit IgG. The filters were then incubated
with avidin-conjugated alkaline phosphatase fol-
lowed by a substrate for colour development.
Data presented herein are representative
examples of experiments performed a minimum
of three times unless otherwise specified.
Results
PGE2 and cAMP inducers elevation ofPDGF B
chain mRNA expression: Treatment of ANA-1
macrophages with PGE2 stimulates the expres-
sion of PDGF B chain mRNA (Fig. 1). PDGF B
chain mRNA is expressed in ANA-1 cells follow-
ing culture with as little as 2 ng/ml of PGE2 and
peak levels were induced at 20ng/ml of PGE2.
Similar results were obtained after incubation of
ANA-1 cells with forskolin, which is known to
stimulate adenylate cyclase activity.9 In contrast,
LPS (1/.tg/ml) minimally induces expression of
PDGF B chain mRNA.
Differential expression of ytokines genes in
response to treatment with LPS andforskolin: To
FIG. 1. Effects of PGE2 and agents which elevate intracellular
cAMP on the expression of PDGF B chain mRNA. ANA-1 cells
were cultured with or without inducing for 6h. Blots were
hybridized sequentially with probes for PDGF B chain and actin.
determine whether the induction of cytokine
mRNA expression was specific for PDGF B chain,
we monitored the expression of IL-lfl and TNF<z
in ANA-1 cells cultured for 4h with either LPS
alone, forskolin alone or both LPS and forskolin
(Fig. 2). Northern blots revealed that only PDGF
B chain mRNA expression was stimulated by for-
skolin alone. In contrast to PDGF B chain mRNA,
the expression of IL-I[ and TNF<z mRNAs were
greatly induced by stimulation with LPS alone.
Furthermore, treatment of ANA-1 cells with LPS
and forskolin only yielded slightly higher levels of
IL-I and TNF<z mRNAs than LPS alone, further
suggesting a stimulatory role for a cAMP-depen-
dent pathway in the control of PDGF B chain
gene expression.
A quantitative analysis of the .expression of
PDGF B chain and TNF<z mRNAs is shown in
Fig. 3. Blots were prepared from ANA-1 cells
treated with either LPS alone, forskolin alone or
both LPS and forskolin for 4 h. Scanning densito-
metric analysis (Fig. 3) revealed that PDGF B
chain mRNA was induced over 40-fold following
treatment with forskolin, and that this level was
not further enhanced by LPS. The induction of
TNF<z mRNA expression by LPS was over 19-fold
and was enhanced to 17-fold by the addition of
forskolin to LPS. LPS alone marginally induced
PDGF B chain mRNA expression, as did forskolin
alone for TNF-z mRNA levels.
Tme course of induction of expression PDGF B
chain mRNA_. ANA-1 cells were cultured with
forskolin (10 IM) for various periods of time
before harvest of cells for RNA isolation and blot
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FIG. 2. Differential expression of cytokine genes in response to treatment with LPS and forskolin. ANA-1 cells were cultured for 4h
with or without LPS (1 Ig/ml) and forskolin (10 IM). Northern blots were sequentially hybridized with the indicated cDNA probes.
6O
20
forskolin untreated LPS forskolin
and LPS
FIG. 3. Expression of PDGF B chain and TNF- mRNAs. Blots
were prepared from ANA-1 cells following 4h of culture with or
without LPS (1 Ig/ml) in the presence or absence of forskolin
(IOIM). Blots containing total cellular RNA were hybridized
probes for PDGF B chain, TNF- and actin. Quantification of
mRNA expression was made by scanning densitometric analysis.
Data are reported as arbitrary optical (O.D.) units.
analysis. PDGF B chain mRNA is marginally
expressed in untreated cells and is rapidly
induced within I h of treatment with forskolin.
Maximal expression is achieved between 4 and
18 h of culture, after which the PDGF B chain
mRNA level gradually declines.
Modulation ofPDGF B chain .mRNA expression
by agents which elevate intracellular cAMP
levels: To confirm that the stimulatory effects, of
forskolin on the expression of PDGF B chain
mRNA expression were due to the enhancement
of cAMP levels, ANA-1 cells were cultured in the
presence or absence of several agents which
elevate intracellular cAMP. These include PGE2
forskolin, dBcAMP, 8-bromo-cAMP, IBMX (an
inhibitor phosphodiesterase and, thus, indirectly
enhancing intracellular levels of cAMP by block-
ing its degradation),
1 and cholera toxin (which
triggers continuous activation of adenylate cyclase
by altering the a subunit of the stimulatory
GTP-binding protein).
1 All of the agents which
triggered the elevation of intracellular cAMP
stimulated the enhanced expression of PDGF B
chain mRNA (Fig. 4). In contrast, the addition of
dBcGMP to ANA-1 cells failed to stimulate levels
of PDGF B chain mRNA above background (not
shown).
Effects of cAMP-inducing agents on PDGF B
chain protein production: Immunoblot analysis
was performed to determine whether incubation
of ANA-1 with cAMP-inducing agents triggered
the production and secretion of PDGF B chain
protein. Fig. 5 shows that PDGF B chain protein
is released by macrophages following culture
with a variety of agents which trigger the accu-
mulation of intracellular cAMP. In contrast, treat-
ment with a cGMP-inducer fails to induce ANA-1
cells to secrete detectable levels of PDGF B chain
protein.
Discussion
The expression of PDGF-like molecules by
macrophages in response to tissue injury has
been well documented (for a review, see Refer-
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FIG. 4. Comparison of effects of agents which elevate cAMP on
PDGF B chain mRNA expression and protein production. ANA-1
cells were cultured for 4 h with or without the following agents:
forskolin (IOIM), LPS (1 lg/ml), dBcAMP (0.1 IM), 8-bromo-
cAMP (0.1 IM), IBMX (0.2mM), PGE2 (20ng/ml), and cholera
toxin (51M). Northern blot analysis reveals that a variety of
agents which induce the accumulation of cAMP trigger the
expression of PDGF B chain mRNA.
FIG. 5. Secretion of PDGF B chain protein by ANA-1 cells. Immu-
noblot analysis of PDGF B chain protein indicates that PDGF B
chain protein is produced and secreted by macrophages follow-
ing treatment with cAMP-inducing agents.
ence 12). Alveolar macrophages from normal
lungs do not spontaneously release PDGF-like
mediators, but can be induced to secrete these
cytokines followinR in vitro treatment with a
variety of agents.-
In contrast, constitutive
production of high levels of PDGF is observed in
macrophages isolated from the lungs of animals
undergoing the repair process following pulmon-
ary injury induced by exposure to cytotoxic
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drugs,v asbestos and hyperoxia,9 as well as
patients with idiopathic pulmona fibrosis,
2-22
adult respiratory disease syndrome,2 and sclero-
derma lung disease (EJ Kovacs et al., unpub-
lished observation). In addition, alveolar lining
fluid collected by pulmonary lavage from bleo-
mycin treated rats2and patients with pulmonary
fibrosis,
25 contains PDGF-like cytokines, suggest-
ing their release in situ.
The involvement of macrophage-derived fibro-
genic cytokines, such as PDGF, in the develop-
ment of fibrosis is not restricted to the lung.
PDGF has been found in the peritoneal fluid of
patients with endometriosis
2 as well as in
patients undergoing peritoneal dialysis
27 or intra-
peritoneal immunotherapy for the treatment of
abdominal tumours.
2u In addition, hyperplasia of
smooth muscle cell and accumulation of extra-
cellular matrix along with a lipid component are
associated with the development of athero-
sclerosis.29 This is believed to result from the
release of a PDGF-like mediator from infiltrating
macrophages. Finally, human wound fluid con-
tains PDGF-like molecules. At present, it is not
clear whether the immunoreactive PDGF descri-
bed herein is identical to the platelet-derived
molecules or similar to the smaller molecular
weight peptides recently described.2’
While these disorders all share the common
denominator of local PDGF release by macro-
phages, it is unclear what triggers the local pro-
duction. Since the release of prostaglandins,
including PGE2, occurs during inflammatory/pre-
fibroti responses, we hypothesized that PGEa
could act in an autocrine/paracrine feed-forward
manner to trigger the production of PDGF B
chain by macrophages.
Our data are in concurrence with other studies
demonstrating a stimulatory role for PGEa and
cAMP-inducers in the control of a subset of mac-
rophage functions, including cholesterol ester
32 33 34 clearance and IL-6 production. The role of
cAMP in the regulation of IL-1 and TNF-t genes
has remained somewhat controversial, with some
laboratories reporting that cAMP inducers inhibit
IL-1 and TNF-a gene expression, while others
state that they stimulate, expression (for a review,
see Reference 35).
With regard to the transcription of IL-1 genes,
studies performed in murine peritoneal macro-
phages demonstrate an inhibitory role for cAMP
36 37 and cAMP-inducers.’ However, in human
monocytes, it acts primarily as a stimulant.-4
Our data reveal that the cAMP inducer, forskolin,
has a marginal stimulatory effect on LPS-induced
expression of IL-1 mRNA in the fetal liver-derived
ANA-1 murine macrophage cell line (Fig. 2).
Thus, the action of cAMP-inducing agents on thecAMP induces expression ofPDGFB chain mRNA
production of IL-1 seems to be species, as well
as cell type, specific.
In conclusion, these data demonstrate that
agents which trigger the accumulation of intracel-
lular cAMP specifically stimulate the expression
of the PDGF B chain gene, without altering the
endogenous or LPS-induced expression of TNF-cz
or IL-113 mRNA. Hence, the expression of cyto-
kine genes may be divided into two classes, ones
(such as PDGF B chain) which are activated by
inducers of cAMP and others (including TNF<z
and IL-113) which are not.
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